Thrivent Financial for Lutherans Sells 51,551 Shares of Chemed Co. (NYSE:CHE)

Thrivent Financial for Lutherans reduced its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 35.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 94,466 shares of the company's stock after selling 51,551 shares during the period. Thrivent Financial for Lutherans owned about 0.63% of Chemed worth $50,048,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. CIBC Asset Management Inc grew its position in Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock worth $242,000 after acquiring an additional 22 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its holdings in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after purchasing an additional 22 shares during the last quarter. EP Wealth Advisors LLC increased its stake in shares of Chemed by 1.9% in the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company's stock worth $814,000 after buying an additional 25 shares during the period. Independent Advisor Alliance raised its holdings in Chemed by 1.1% during the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock valued at $1,207,000 after buying an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Chemed by 7.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after buying an additional 33 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Brian C. Judkins purchased 145 shares of the stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of analyst reports. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their price target on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a report on Friday, March 14th.

Chemed Stock Performance

CHE stock traded up $12.82 on Monday, reaching $606.93. The company's stock had a trading volume of 119,185 shares, compared to its average volume of 89,104. The business has a fifty day simple moving average of $567.72 and a two-hundred day simple moving average of $565.35. The firm has a market cap of $8.88 billion, a PE ratio of 30.67, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $648.29.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is 10.05%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.